Hippocratic AI Announces New Key Executive Appointments to Further Accelerate Growth

Additional Executive Hires to Support Safe, Responsible Scaling of Generative AI Healthcare Agents

MAIN Hippocratic Logo Full Color
MAIN Hippocratic Logo Full Color

PALO ALTO, Calif.–(BUSINESS WIRE)–#GenAI–Hippocratic AI, a global leader and pioneer of generative AI healthcare agents, today announced several strategic executive appointments as the company continues to scale its platform across providers, payors, and life sciences organizations. The additions strengthen Hippocratic AI’s clinical leadership, operational depth, and go-to-market execution as demand accelerates. The appointments follow Hippocratic AI’s $141 million Series C financing announced in November.

As Hippocratic AI scales, building a leadership team grounded in clinical credibility, operational rigor, and patient safety is non-negotiable,” said Munjal Shah, CEO of Hippocratic AI. “These leaders bring decades of experience across healthcare, AI, and enterprise execution, and they will play a critical role in helping us continue to scale implementation of generative AI healthcare agents responsibly, at scale, and in service of healthcare abundance.”

New Executive Appointments:

  • Dr. Anoop Sangha, MD, Associate Chief Medical Officer

    Anoop brings more than two decades of clinical practice and physician leadership experience across digital health, payor, and provider organizations. He has held senior clinical leadership roles at Transcarent, Livongo (Teladoc Health), Optum, and the Advisory Board Company, where he helped scale AI-enabled care models, remote patient monitoring, and clinical programs spanning navigation, chronic care, and population health. Dr. Sangha is board-certified in Emergency Medicine and is known for bridging clinical rigor with product, operational, and commercial strategy to drive measurable impact.
  • Dr. Eduardo Reis, MD, Vice President, Strategy (Office of the CEO)

    Eduardo Pontes Reis, MD has joined Hippocratic AI as part of the Office of the CEO, bringing deep expertise at the intersection of clinical medicine, medical imaging, and artificial intelligence. A neuroradiologist and AI researcher, he has held leadership and research roles at Stanford’s Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Hospital Israelita Albert Einstein, where he has focused on building, evaluating, and deploying AI systems for real-world clinical use. Recently he has served as Founding Radiologist at a fast-growing radiology AI startup, acquired by a large radiology group. Dr. Reis brings a strong track record in medical AI to support Hippocratic AI’s executive strategy and product development.
  • Niloy Sanyal, Chief Marketing Officer

    Niloy brings over 20 years of experience building and scaling healthcare, AI, and enterprise SaaS companies, with a track record of shaping category-defining brands and driving sustained growth in highly regulated markets. He has held senior leadership roles at LeanTaaS, Omnicell, and GE Digital, where he led global marketing and go-to-market functions, launched enterprise platforms, and partnered closely with product and sales teams to accelerate adoption across health systems and life sciences organizations. Across these roles, Niloy is known for translating complex technologies into clear value propositions, building high-performing teams, and establishing durable market leadership.

These appointments reinforce Hippocratic AI’s commitment to building safe generative AI healthcare agents that improve access and health outcomes as the company continues to scale.

About Hippocratic AI

Hippocratic AI has developed the safest generative AI Agents for healthcare. The company believes that generative AI has the ability to bring healthcare abundance to every person in the world. The company focuses on building non-diagnostic patient-facing clinical AI agents and does not allow its agents to be used to prescribe or diagnose. Hippocratic AI has received a total of $404 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA’s NVentures, Premji Invest, SV Angel, Google’s CapitalG, and numerous health systems. Learn more at https://hippocraticai.com/.

Contacts

Media Contact

Rick Keating

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.